Healthy Returns: Novo Nordisk’s head of research and development previews the first-ever obesity pill  (2025-09-03)
Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.